Approved indications: Probenecid is approved to lower uric acid in chronic gout and gouty arthritis, and as an add‑on to specific penicillin‑type antibiotics (such as ampicillin, methicillin, oxacillin, cloxacillin, and nafcillin) to raise and prolong their blood levels; probenecid is also included in a fixed‑dose oral combination with sulopenem for certain uncomplicated urinary tract infections in adult women who have limited oral treatment options.

Off‑label and adjunctive uses: Clinicians may use probenecid off‑label to enhance blood levels of some cephalosporins and other beta‑lactam antibiotics, and alongside drugs such as cidofovir to reduce kidney toxicity, based mainly on pharmacokinetic studies, small clinical trials, and long clinical experience rather than large modern outcome trials.

Efficacy in gout and hyperuricemia: When taken every day, probenecid usually lowers serum uric acid within a few weeks, but gout flares may initially increase before gradually improving over several months as uric acid deposits dissolve; many appropriately selected patients with good kidney function can reach target uric acid levels, though response rates are generally lower than with xanthine‑oxidase inhibitors such as allopurinol or febuxostat, so probenecid is often reserved for patients who cannot tolerate or do not respond adequately to those drugs.

Efficacy as an antibiotic booster: Probenecid increases antibiotic levels from the first doses, helping maintain therapeutic concentrations between doses; this can allow less frequent dosing of some agents or higher effective exposure, but it does not replace the need for an appropriate antibiotic choice based on the infection and local resistance patterns.

Efficacy in UTI combination therapy: In the fixed‑dose sulopenem/probenecid product, symptom relief from uncomplicated urinary tract infection typically begins within a few days, with clinical cure rates comparable to other effective oral antibiotics in the specific adult female population for whom it is approved.

How to take probenecid: Take tablets by mouth, usually with food or an antacid to reduce stomach upset, swallow with a full glass of water, and drink plenty of fluids throughout the day to help prevent kidney stones, unless your clinician has given you different fluid instructions.

Typical adult dosing for gout and hyperuricemia:

• Start at 250 mg twice daily for 1 week, then increase to 500 mg twice daily.
• If gout symptoms are not controlled and kidney function is adequate, the dose can be increased in 500‑mg per day steps every 4 weeks, usually not exceeding a total of 2 g (2,000 mg) per day, divided into 2–4 doses.
• Therapy is long term; stopping or taking it irregularly can cause uric acid levels to rise again and gout attacks to recur.
• Probenecid should generally be started only after an acute gout attack has fully settled; if an attack occurs while you are already on probenecid, do not stop it on your own, but your clinician may add or adjust anti‑inflammatory medicines for the flare.

Typical dosing when used with antibiotics:

• As a general penicillin “booster” in adults, a common regimen is 2 g per day in divided doses (for example, 500 mg four times daily), with lower doses or extra caution in older adults or those with reduced kidney function.
• In children 2–14 years old receiving certain penicillin‑class antibiotics, dosing is usually based on body weight (for example, an initial dose around 25 mg/kg per day followed by about 40 mg/kg per day in 4 divided doses), and is determined by the pediatric prescriber.
• In fixed‑dose combinations (such as sulopenem/probenecid), follow the specific dosing schedule on that product’s label.

Special dosing instructions: Your dose may need adjustment based on uric acid levels, the frequency of gout attacks, kidney function, age, and any medicines that interact with probenecid; do not change the dose or stop the drug without consulting your prescriber.

Missed dose guidance: If you miss a dose, take it as soon as you remember unless it is almost time for your next scheduled dose; in that case skip the missed dose and resume your regular schedule—do not double up doses.

Overdose: Taking too much probenecid can increase the risk of severe nausea and vomiting, dizziness, kidney problems, or serious blood or allergic reactions; in case of suspected overdose, contact a poison control center or emergency medical services immediately, and bring the medication container with you if possible.

Common side effects (often mild):

• Stomach upset, nausea, vomiting, loss of appetite, or sore gums, which are more likely at higher doses and can improve if the dose is lowered or taken with food.
• Headache, dizziness, flushing, or mild rash.
• More frequent gout attacks during the first months of treatment as uric acid levels start to fall.

Serious or rare adverse effects – seek urgent medical attention if:

• Signs of a severe allergic reaction such as trouble breathing, chest tightness, swelling of the face, lips, tongue, or throat, or widespread hives or severe rash.
• Severe skin reactions, unexplained fever, or swollen glands.
• Blood problems such as unusual bruising or bleeding, extreme tiredness, pale skin, or infections that occur more often than usual (which may signal anemia, low white cells, or other blood disorders).
• Kidney problems such as severe back or side pain, blood in the urine, painful or difficult urination, sudden decrease in urine, or symptoms suggesting kidney stones (sharp flank pain, nausea, vomiting).
• Severe abdominal pain, dark urine, yellowing of the skin or eyes, or other signs of liver injury.

Warnings and precautions:

• Do not use in children under 2 years of age, in people with known blood dyscrasias (serious blood disorders), or those with uric‑acid kidney stones; it is generally ineffective and not recommended in people with significant chronic kidney disease.
• Use cautiously in those with a history of peptic ulcer disease, prior kidney stones, or kidney or liver disease, and in people with glucose‑6‑phosphate dehydrogenase (G6PD) deficiency because of a higher risk of hemolytic anemia.
• Pregnancy and breastfeeding: human data are limited; animal data have not shown clear harm, but use is generally reserved for situations where the expected benefit outweighs potential risks, and alternatives are considered first.
• Older adults may be more sensitive to kidney‑related side effects and drug interactions and may require lower doses and closer monitoring.
• Probenecid can make certain medicines (for example, some beta‑lactam antibiotics, methotrexate, and some antivirals and NSAIDs) stay in the body longer, which can increase both their benefits and their toxicity; doses of these drugs may need adjustment and closer monitoring.

Overall safety compared with other treatments: Compared with newer urate‑lowering drugs, probenecid has a long track record but is more likely to cause kidney stone problems and is less effective in patients with reduced kidney function, so many guidelines now reserve it for patients who cannot use or do not respond to first‑line agents like allopurinol or febuxostat.

Reporting side effects and safety updates: Patients in the United States can report suspected side effects directly to the FDA through the MedWatch program (online or by phone) and should review the most recent patient information or Medication Guide and FDA drug safety communications for updates about probenecid.

Major drug and product interactions:

• Antibiotics: Probenecid is intentionally combined with many penicillins and some cephalosporins to raise their blood levels; however, this also increases the risk of antibiotic side effects, so other interacting medicines (such as additional nephrotoxic drugs) must be reviewed carefully.
• Methotrexate and other weak‑acid drugs: Probenecid can markedly reduce kidney clearance of methotrexate and some similar medicines, increasing toxicity; if they must be used together, lower methotrexate doses and close monitoring of blood counts, kidney function, and drug levels are often required.
• Antivirals and NSAIDs: It can raise levels of some antivirals (such as acyclovir‑type drugs and cidofovir when used with it) and certain NSAIDs (for example, indomethacin), which may increase both benefit and side effects; some combinations, such as with ketorolac, are generally avoided.
• Salicylates and some diuretics: Aspirin and other salicylates can blunt or reverse the uric‑acid‑lowering effect of probenecid, and high‑dose loop or thiazide diuretics and heavy alcohol use can raise uric acid, making probenecid less effective; always check with your clinician before using over‑the‑counter pain relievers with probenecid.
• Other medicines: Probenecid can affect the handling of sulfonylurea diabetes medicines, some sulfonamides, and other drugs that share the same kidney transport pathways, so all prescription, nonprescription, and herbal products should be reviewed for potential interactions.

Precautions and situations where use may be unsafe:

• History of uric‑acid kidney stones, significant chronic kidney disease, or severely reduced urine flow, because probenecid can promote stone formation and is less effective when kidney function is poor.
• Existing blood disorders (blood dyscrasias) or prior severe reaction to probenecid or chemically related medicines.
• Children under 2 years of age, in whom probenecid is contraindicated.
• People with active peptic ulcer disease or severe gastrointestinal disease, where probenecid‑related GI irritation could be harmful.
• Pregnancy and breastfeeding, where the decision to use probenecid should weigh the expected benefits against limited human safety data and consider alternative therapies.

Monitoring needs:

• Serum uric acid levels to ensure the drug is effectively lowering uric acid to the target range for gout prevention.
• Kidney function tests (such as serum creatinine and estimated GFR) and, when appropriate, urinalysis to watch for kidney stones or other renal problems.
• Complete blood counts if there are symptoms suggesting anemia, infection, or bruising, or when probenecid is combined with drugs that can affect the bone marrow.
• Clinical monitoring for side effects and drug interactions whenever new medicines, over‑the‑counter products, or supplements are started or stopped.

Q: How long does it take for probenecid to start helping my gout?
A: Blood uric acid levels usually begin to fall within a few weeks, but it can take several months of daily treatment before gout attacks become noticeably less frequent.

Q: Why did my gout attacks get worse after starting probenecid?
A: As stored uric acid begins to dissolve and move out of joints, flares may temporarily increase during the first months; this does not mean the drug is failing, and your clinician may add medicines like colchicine or NSAIDs to control early flares.

Q: Can I take probenecid if I already use allopurinol or febuxostat?
A: In some cases, probenecid is added to a xanthine‑oxidase inhibitor such as allopurinol or febuxostat when uric acid remains above target, but this combination requires careful monitoring of kidney function, uric acid levels, and drug interactions.

Q: Is probenecid safe if I have kidney problems?
A: Probenecid is usually avoided or used very cautiously in people with moderate to severe chronic kidney disease or a history of uric‑acid kidney stones, because it may not work well and can increase the risk of stones or kidney injury.

Q: Can I drink alcohol while taking probenecid?
A: Occasional light drinking may be allowed for some people, but alcohol can raise uric acid and trigger gout attacks, so many clinicians recommend limiting or avoiding alcohol—especially beer and spirits—while on probenecid.

Q: Do I take probenecid only during a gout attack?
A: No; probenecid is meant to be taken every day as long‑term urate‑lowering therapy to prevent future attacks, not as a treatment for pain during an acute flare.

Storage: Store probenecid tablets at room temperature (about 68–77°F or 20–25°C) in a tightly closed container, away from moisture, heat, and direct light, and do not freeze.

Safety: Keep the medicine out of the reach of children and pets, and keep tablets in the original labeled container to avoid mix‑ups.

Disposal: Do not use tablets that are expired, damaged, or no longer needed; use a pharmacy or community drug take‑back program when possible, or, if none is available, mix unused tablets with an undesirable substance (such as used coffee grounds or cat litter), seal in a bag or container, and place in household trash rather than flushing them.